FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models
Article in Scientific Reports (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target
Article in International Immunopharmacology (February 2023)
Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors
Article in Cytokine & Growth Factor Reviews (September 2022)